Sign in
TerminatedPhase 1/2

Ultrasonic Neuromodulation for Treatment of Cognitive Impairment

Key facts

Who runs it
University of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 1/2
People taking part
1 person enrolled
Started
18 Aug 2024
Ended
21 Aug 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Diadem prototype
Record updated
25 May 2025
Why it stopped
IRB administrative closure

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Mild cognitive impairment or mild dementia due to Alzheimer's disase (AD) with confirmed AD biomarkers (Amyloid PET or CSF)
  • Age 65-80
  • MOCA > 18

Who cannot take part

  • Evidence of cerebral amyloid angiopathy or stroke within 1 year
  • Clinical symptoms or findings suggestive of alternative diagnosis or co-pathology
  • Inability to complete MRI
  • Suicidal ideation

Where in United States

  • University of UtahSalt Lake City, United States

About the trial

What the trial wants to find out

This study will evaluate a new form of non-invasive deep brain therapy for individuals with Alzheimer's disease. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The trial will evaluate brain target engagement using magnetic resonance imaging, PET imaging, and numerical scales of cognitive performance.

The 2 groups in the trial

  • Active stimulationTreatment being tested

    Low-intensity transcranial focused ultrasound stimulation of deep brain targets affected by Alzheimer's disease.

    Treatment: Diadem prototype

  • Sham stimulationSham treatment, for comparison

    Sham stimulation that applies the device in the same way as verum but only delivers auditory sounds correspoding to the ultrasonic pulses.

    Treatment: Diadem prototype

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Cognitive Impairment
Record updated
25 May 2025